Dermal Blood Flow Response to Escalating Doses of Histamine, Administered by a Skin Prick

NCT04399213 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Pruritus

Interventions

PROCEDURE: 50 µg Histamine
PROCEDURE: 15 µg Histamine
PROCEDURE: 5 µg Histamine
PROCEDURE: Placebo (saline)

Sponsor

Universitaire Ziekenhuizen KU Leuven